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Abstract
Grape polyphenols can act as antioxidants, antiangiogenics, and selective estrogen receptor (ER) modifiers and
are therefore especially relevant for gynecological cancers such as breast cancer. The major polyphenols of red
wine (resveratrol, quercetin, and catechin) have been individually shown to have anticancer properties. However,
their combinatorial effect on metastatic breast cancers has not been investigated in vivo. We tested the effect of
low dietary concentrations of resveratrol, quercetin, and catechin on breast cancer progression in vitro by analy-
zing cell proliferation and cell cycle progression. The effects of these compounds on fluorescently tagged breast
tumor growth in nude mice were assessed using in situ fluorescence image analysis. Individual polyphenols at
0.5 μM neither decreased breast cancer cell proliferation nor affected cell cycle progression in vitro. However,
a combination of resveratrol, quercetin, and catechin at 0.5, 5, or 20 μM each significantly reduced cell prolifera-
tion and blocked cell cycle progression in vitro. Furthermore, using in situ image analysis, we determined that
combined dietary polyphenols at 0.5, 5, or 25 mg/kg reduced primary tumor growth of breast cancer xenografts
in a nude mouse model. Peak inhibition was observed at 5 mg/kg. These results indicate that grape polyphenols
may inhibit breast cancer progression.
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Introduction
Grapes and red wine are thought to have cancer and cardiovascular
health benefits due to polyphenolic compounds from grape skin [1].
Grape polyphenols can act as antioxidants, antiangiogenics, and se-
lective estrogen receptor (ER) modifiers and are therefore especially
relevant for gynecological cancers such as breast cancer [2–4]. The
anticancer effects of grape polyphenols, which are concentrated in
red wine, have been demonstrated in numerous in vitro and in vivo
systems, including breast cancer models [5–13]. These compounds
elicit increased growth-inhibitory effects on mouse mammary cells
in culture and in vivo systems [7].
The compounds resveratrol, quercetin, and catechin selected for
this study represent about 70% of the red wine polyphenols
[6,14]. All three have antioxidant properties and, due to structural
similarity to the steroid hormone estrogen, can have both estrogenic
and antiestrogenic effects (Figure 1) [2,4,15]. Interestingly, resveratrol,
quercetin, and catechin are the most effective anticancer compounds
in red wine in a mouse skin cancer model [16]. Additionally, all three
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polyphenols are considered viable chemopreventives because they are
absorbed in vivo and can be detected intact in plasma and urine sam-
ples in humans and rodent models. However, these compounds are
metabolized rapidly following digestion and the plasma levels can be
relatively low [5,17–21]. Individually, each of these compounds has
been shown to induce cell cycle arrest and apoptosis in cancer cells
[22–26], as well as prevent breast carcinogenesis and cancer progres-
sion in rodent models [27–31].
Herein, we report a study aimed at understanding the preventive
and therapeutic efficacy of combined resveratrol, quercetin, and cat-
echin on breast cancer. We show that dietary concentrations of these
grape polyphenols can inhibit breast cancer cell proliferation in vitro
and mammary tumor growth in vivo.
Materials and Methods
Cell Culture
MDA-MB-231 human breast cancer cells (American Type Culture
Collection) were transfected with pMax–enhanced green fluorescent
protein (GFP) plasmid by nucleofection according to the manufac-
turer,s instructions (Amaxa Inc., Gaithersburg, MD). Stable GFP-
expressing clones were selected and cultured in Dulbecco,s modified
Eagle,s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) at 37°C in 5% CO2.
Cell Proliferation
Semiconfluent cells seeded on six-well plates in phenol red–free
DMEM and 5% FBS (charcoal-stripped) were treated either with
vehicle or with polyphenols (0.5, 5, or 20 μM each of resveratrol,
quercetin, or catechin or a combination of resveratrol, quercetin,
and catechin at 0.5, 5, or 20 μM) every 48 hours for 96 hours. Stock
solutions of resveratrol, quercetin, and catechin (LKT Laboratories,
St. Paul, MN) in 100% ethanol were diluted in DMEM to a final
concentration of 0.1% (v/v) ethanol before treatment. Cells were
fixed in methanol, stained with propidium iodide (PI), and intact
nuclei were counted from digital images acquired using a microscope
(Model CKX41; Olympus America, Inc., Center Valley, PA). The
total number of cells was quantified from 30 microscopic fields per
well from experiments carried out on two separate days with each
treatment done in triplicate (N = 6).
Cell Cycle Analysis
Cells were seeded at a density of 5 × 105 on 10-cm plates in 5%
FBS, phenol red–free medium. Cells were treated either with vehicle
(0.1% ethanol) or with polyphenols (0.5, 5, or 20 μM each of res-
veratrol, quercetin, or catechin or a combination of resveratrol, quer-
cetin, and catechin at 0.5, 5, or 20 μM) every 48 hours for 96 hours.
Cells were harvested, fixed in 70% ethanol, and stained with 40 μg/
ml PI. At least 40,000 cells were analyzed per sample using a FACS-
Calibur machine (Becton Dickinson, San Jose, CA). Flow cytometry
data analysis was performed using a software (FlowJo 7.2.1; Tree Star,
Inc., San Carlos, CA). Samples from each treatment were gated sim-
ilarly and the mean percentage of cells in the G0/G1, S, and G2/M
phases was quantified from FL2-A histograms using the Dean-Jett-
Fox Model. One-way analysis of variance with posttest was done for
each cell cycle stage using a software (GraphPad InStat 3 Version 3.06;
GraphPad, San Diego, CA).
In Vivo Experiments
As diagrammed in Figure 2, animal experiments were designed
to determine the effect of dietary polyphenols on established mam-
mary tumors.
Animals. Female athymic nu/nu mice, 5 to 6 weeks old (Charles
River Laboratories, Inc., Wilmington, MA), were maintained in high-
efficiency particulate air–filtered cages in a pathogen-free facility.
Mice were fed autoclaved diet (Tek Global; Harlan Teklad, Madison,
WI) with 14% protein and 3.5% fat and minimal alfalfa or soybean
meal that may contain phytoestrogens.
Figure 1. Structures of red wine polyphenols. Structures of the stilbene resveratrol, flavan-3-ol catechin, and flavonol quercetin are com-
pared with estrogen. These polyphenols can act as antioxidants and may have estrogenic/antiestrogenic activity due to similarity in
distance between terminal hydroxyl groups of estrogen that can interact with estrogen receptors.
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Tumor establishment. GFP–MDA-MB-231 cells (∼ 2 × 106) in
Matrigel (BD Biosciences, San Jose, CA) were injected into the
mammary fat pad of three female nude mice according to established
protocols [32]. When tumors reached 20 to 30 mm2, they were har-
vested, pooled, and segmented into ∼ 2 mm3 xenografts which were
immediately implanted into the mammary fat pad of 40 female nude
mice as previously described [33]. A small incision was made at the
mammary fat pad and the xenograft was implanted under the skin,
followed by closure of incision using staples. The efficiency of xeno-
graft establishment was 100% as determined by palpation and mea-
surement of fluorescence intensity at the site of implantation.
Polyphenol administration. Nude mice (10 mice per treatment
group) were gavaged either with vehicle (90% corn oil and 10% eth-
anol) or with combined resveratrol, quercetin, and catechin at 0.5, 5,
and 25 mg/kg body weight in a 100-μl volume thrice a week starting
at 1 day after xenograft implantation. Treatments continued until
sacrifice at day 118.
Macroscopic fluorescence image analysis. Hand-restrained mice
were imaged immediately following xenograft implantation and twice
a week thereafter. A 300-W power source (LT99D2; Lightools Re-
search, Encinitas, CA) with two optical delivery systems fitted with
excitation filters (470/40 nm) was used for whole body imaging of
GFP fluorescence. Images were captured with a charge-coupled de-
vice camera (Spot II; Diagnostic Instruments, Sterling Heights, MI)
mounted with a 530/25 nm emission filter (Chroma Technology,
Rockingham, VT). GFP fluorescence was quantified as a measure
of tumor growth as per our previously described methods [34].
Tumor area was manually traced as delineated by fluorescence and
fluorescence intensities were analyzed using Adobe Photoshop 7.0
(Adobe Systems Incorporated, San Jose, CA) and ImageJ software
(National Institutes of Health (NIH), Bethesda, MD). Relative
tumor area for each mouse was calculated as the tumor area at
each imaging session divided by the tumor area directly after xeno-
graft implantation.
Results
Grape Polyphenols Inhibit Breast Cancer Cell Proliferation
and Cell Cycle Progression In Vitro
The effect of grape polyphenols on cell proliferation was analyzed
in vitro using ERα (−) ERβ (+) GFP–MDA-MB-231. Cells in 5%
charcoal-stripped serum and phenol red–free media were treated with
individual resveratrol, quercetin, or catechin at 0.5, 5, or 20 μM, or a
combination of 0.5, 5, or 20 μM resveratrol, quercetin, and catechin
for 96 hours. At 48 hours, the old media was removed and fresh
compounds and media were added to the cells. Therefore, the con-
centrations of compounds that were perceived by the cells at end
point may be slightly higher because of the potential for unmetabo-
lized compounds inside the cells from the initial treatment. At
0.5 μM, treatment with resveratrol, quercetin, or catechin alone
did not demonstrate any changes in cell number or nuclear morphol-
ogy. However, combined resveratrol, quercetin, and catechin at
0.5 μMdramatically reduced cell number (Figure 3A). Individual res-
veratrol or quercetin at 5 or 20 μM, catechin at 20 μM, or a com-
bination of resveratrol, quercetin, and catechin at 0.5, 5, or 20 μM
each reduced cell number significantly compared to control (Figure 3B).
Quercetin demonstrated a biphasic regulation of cell proliferation with a
significant increase at 0.5 μM and decrease at 5 and 20 μM. Catechin
alone was not as effective as resveratrol or quercetin at all concentrations
tested. However, at 5 and 20 μM catechin, there was a disproportionate
number of larger cells with larger segmented nuclei, indicating a dif-
ferent mechanism of regulation by catechins (Figure 3A). Combination
of all three compounds at 0.5, 5, or 20 μM reduced cell number by
65%, 83%, and 98%, respectively, and cells demonstrated apoptotic
nuclei (Figure 3).
The synergistic effect of a low (0.5 μM) concentration of polyphe-
nols on cell proliferation was also confirmed by analysis of cell cycle
progression using flow cytometry of PI-stained cells. Individual treat-
ment of 0.5 μM each resveratrol, quercetin, or catechin did not affect
cell cycle progression. However, a combination of resveratrol, quer-
cetin, and catechin at 0.5 (Figure 4) or 5 μM (data not shown) each
increased the percentage of cells at S phase with a concomitant de-
crease at G2/M phase of the cell cycle in a statistically significant
manner, when compared to control. At 5 μM, resveratrol was the
most potent polyphenol with reduced cell numbers at G1, a statisti-
cally significant increase in the average number of cells at S phase,
and a concomitant decrease in cell numbers at G2/M, when com-
pared to control. At 20 μM each, consistent with the large decrease
in cell numbers, resveratrol, quercetin, or combined polyphenol
treatment resulted in cell cycle arrest at G0/G1 by demonstrating in-
creased percentage of cells at G1 with drastically reduced numbers at
S and G2 phases. The effect of catechin on cell proliferation and cell
cycle progression was different by demonstrating an increase in cells
at S phase at 20 μM consistent with the observed difference in
Figure 2. Schematic design of the animal experiments. Six-week-old female nude mice were acclimated for 2 weeks and GFP–MDA-MB-
231 xenografts were inoculated at the mammary fat pad at 8 weeks of age (day 0). On day 1, mice were administered vehicle, 0.5, 5, or
25 mg/kg each of resveratrol, quercetin, and catechin thrice a week for 117 days. Fluorescence image analysis of tumors commenced
on day 0 and continued twice a week until the end of the study at 118 days (32 weeks).
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nuclear morphology compared to resveratrol or quercetin at similar
concentrations (Figure 3).
Grape Polyphenols Inhibit Breast Cancer Growth In Vivo
To investigate the physiological relevance of the observed reduc-
tion in breast cancer cell number and the inhibition of cell cycle
progression in response to grape polyphenols, we tested the effect
of combined resveratrol, quercetin, and catechin treatment on tumor
growth from MDA-MB-231 cells in vivo. Xenografts of GFP–MDA-
MB-231 cells, ∼ 2 mm2 in size, were implanted in the mammary fat
pads of female athymic nude mice and tumor growth was monitored
using fluorescence image analysis for 118 days.
During the course of the study, nude mice implanted with GFP-
tagged MDA-MB-231 xenografts did not show a difference in body
Figure 3. Effect of grape polyphenols on MDA-MB-231 cell proliferation. MDA-MB-231 cells at a density of 5 × 104 in 5% charcoal-
stripped FBS and phenol red–free media were plated on six-well plates. After 4 hours and every 48 hours for 96 hours, cells were treated
with vehicle (Veh), 0.5, 5, or 20 μM resveratrol (Res), quercetin (Quer), or catechin (Cat), or a combination of 0.5, 5, or 20 μM each Res,
Quer, and Cat (RQC). Cells were fixed and nuclei were stained with PI. (A) Representative micrographs of cells stained with PI. (B) Cell
proliferation as analyzed by quantification of intact (nonapoptotic) nuclei. Percent viable cells ± SEM for 10 microscopic fields per trip-
licate treatments (N = 30) were calculated.
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weight (Figure 5), indicating that polyphenol treatment, ethanol in-
take, and/or tumor burden did not significantly affect weight.
Each mouse was imaged twice a week and the relative tumor area
was calculated as a function of the fluorescence intensity of the tumor
on day 1 directly after xenograft implantation. Therefore, data rep-
resent the change in tumor intensity from time of implantation for
each individual mouse in all of the groups tested. Figure 6 demon-
strates that treatment with 0.5, 5, or 25 mg/kg body weight of
resveratrol, quercetin, and catechin decreased tumor growth com-
pared to controls. Tumor growth increased in a linear fashion in re-
sponse to 0.5 and 5 mg/kg combined polyphenol treatments. From
the concentrations tested, a maximum inhibitory effect was achieved
Figure 4. Effect of grape polyphenols on MDA-MB-231 cell cycle progression. MDA-MB-231 cells at a density of 5 × 105 in 5% charcoal-
stripped FBS and phenol red–free media were plated on 10-cm plates. After 4 hours and every 48 hours for 96 hours, cells were treated
with vehicle (Veh), or with 0.5 μM each resveratrol (Res), quercetin (Quer), or catechin (Cat), or a combination of 0.5 μM each Res, Quer,
and Cat (RQC). Cells were fixed and nuclei were stained with PI. Percentage of cells at each cell cycle stage was quantified by flow
cytometry of PI-stained cells. (A) Representative histograms (FL-2A) for cells treated with vehicle or polyphenols. (B) Average percentage
of cells at each cell cycle stage for vehicle or polyphenol treatment. Results shown are for N = 3 ± S.D. Asterisks indicate statistical
significance (P < .05) when compared to Veh controls.
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using 5 mg/kg combined polyphenols. At all concentrations tested,
the polyphenol treatments resulted in an initial lag in tumor estab-
lishment compared to controls where the slope for increase of control
tumor intensity from day 1 to 20 was 0.09, whereas 0.5, 5, or
25 mg/kg body weight treatments resulted in a slope of − 0.03. At
20 days post xenograft implantation, tumors from mice treated with
0.5 mg/kg treatments increased in intensity with a slope of 0.028,
tumors from 5 mg/kg treatments with a slope of 0.017, and tumors
from 25 mg/kg treatments with a slope of 0.014 (Figure 6A).
At 118 days postimplantation, the average mammary tumor area
increased 4.8-fold compared to day 0 in control mice treated with
vehicle alone; for mice treated with grape polyphenols at 0.5, 5,
and 25 mg/kg, this average increase was 3-fold, 1.5-fold, and 1.6-
fold, respectively. Decrease in tumor growth was observed visually
on inspection of change in tumor fluorescence area and intensity.
Treatments at 5 and 25 mg/kg showed a statistically significant re-
duction in mammary tumor growth relative to control mice treated
with vehicle alone (Figure 6, B and C ).
Discussion
This study was designed to determine the combinatorial effect of
polyphenols at dietary concentrations on established mammary tu-
mors. Most investigations on environmental and dietary chemopre-
ventives focus on breast cancer initiation and not on established
mammary tumors. Studies conducted with chemically induced as
well as spontaneous carcinogenic transgenic mouse models have
Figure 5. Effect of grape polyphenols on mouse body weight.
Mice were weighed weekly. Initial and final body weights (BW)
are shown. Data are represented as weight ± SEM for 10 mice
per treatment group.
Figure 6. Effect of grape polyphenols on mammary tumor growth. Mice were administered with vehicle (10% ethanol in oil) or with 0.5,
5 or 25 mg/kg resveratrol, quercetin, and catechin (RQC) thrice a week. GFP–MDA-MB-231 xenografts (∼ 2 mm2) were inoculated in the
right mammary fat pad of female athymic nude mice. Tumor growth was analyzed from digital fluorescent images and made relative to
each image acquired on day 0 immediately following inoculation. (A) Average relative tumor growth as analyzed by the increase in pixel
intensity for 10 mice per experimental group. Regions of green fluorescence from unsaturated digital images were outlined to define
tumor area. Tumor area (in pixels) and average intensity were acquired using ImageJ software (NIH). (B) Representative digital images of
primary GFP mammary tumors from mice treated with dietary polyphenol treatments on days 0 and 118. (C) Quantification of mammary
tumor growth from digital images acquired twice a week for 118 days. Relative tumor area from mice treated with dietary treatments on
day 118. Asterisks denote a statistically significant difference (P < .05) from control.
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demonstrated the use of red wine solids, grape juice, or grape seed
extract in the prevention of mammary tumor initiation [9–13].
However, many studies on the potential anticancer properties of
grape polyphenols have been conducted using concentrations too
high to be achieved using dietary consumption. Moreover, a majority
of these reports investigates the effect of individual polyphenols. Pre-
vious studies in rodents including breast cancer models have demon-
strated the cancer-preventive efficacy of individual treatments of
resveratrol, quercetin, or catechins at pharmacological concentrations
[28–31, 35–37]. Because the majority of dietary compounds contain a
mixture of polyphenols, it is important to understand their combina-
torial effect at dietary concentrations.
The MDA-MB-231 low metastatic human breast cancer cell line
was used to represent an aggressive breast cancer cell line that will
illustrate the utility of using red wine polyphenols as preventives/
therapeutics for advanced breast cancer. This cell line has been used
in vitro to demonstrate the inhibitory effect of red wine polyphenols
at low concentrations [6]. Moreover, our previously published data
using this cell line has demonstrated that resveratrol can have bi-
phasic concentration-dependent effects on cell functions relevant to
breast cancer metastasis such as migration, invasion, and actin cyto-
skeletal changes as well as Akt and focal adhesion kinase activities
that regulate cancer cell survival and invasion [38–40].
Data presented herein illustrate the utility of using a combination
of grape polyphenols as breast cancer chemopreventives and thera-
peutics. The grape polyphenol concentrations used in the in vitro
studies fall within the range of 0.1 to 10 μM that may be accumu-
lated in the circulation following consumption of products rich in
grapes such as red wine [5,19–21,38–42]. However, caution must
be used with the interpretation of in vitro data because the com-
pounds that were added to the tissue culture cells are relatively stable
in their aglycone forms compared to the dietary polyphenols that ac-
cumulate in the blood following oral administration.
Our in vitro data demonstrate that, individually, resveratrol, quer-
cetin, or catechin at a dietary concentration of 0.5 μM does not exert
a significant inhibitory effect on ERα (−) ERβ (+) MDA-MB-231
breast cancer cell proliferation or on cell cycle progression. Interest-
ingly, combined resveratrol, quercetin, and catechin each at 0.5 μM
exerted a synergistic effect to result in cell cycle arrest and reduced
cell proliferation. Decreased cell proliferation and G2/M phase arrest
in response to a similar combination of polyphenols have been re-
ported for breast cancer cells but not for normal mammary epithelial
cells, indicating the utility of grape polyphenols as breast cancer ther-
apeutics [6,23,43]. The subtle but statistically significant increase in
cell numbers in response to low concentrations of quercetin has been
previously reported for other cell types [44]. As demonstrated previ-
ously [24,45–47], resveratrol and quercetin were potent inhibitors of
cell proliferation at high concentrations. The effect of catechin on
cell proliferation and cell cycle progression was modest even at
20 μM. Therefore, catechin may not have contributed to the anti-
cancer properties of grape polyphenols at the concentrations tested.
However, because catechin is the major monomeric polyphenol in
red wine [31,48], catechin was included in the in vivo study on
the effect of grape polyphenols on breast cancer progression.
The in vivo effect of combined dietary treatment of resveratrol,
quercetin, and catechin was quantified by intravital image analysis
of fluorescently tagged breast tumor growth in nude mice. We and
others have demonstrated the utility of such noninvasive imaging
modalities for in situ tumor analysis from the time of tumor cell in-
oculation to the formation of distant metastases from fluorescently
tagged cancer cells in rodent models [34,49,50].
In mice with an average bodyweight of 20 g, 5 mg/kg bodyweight of
each compound in a 100-μl gavage volume equates to 4.38 μM resver-
atrol, 3.3 μM quercetin, and 3.48 μM catechin. These concentrations
are found in dietary components rich in grape polyphenols such as red
wine [14]. A growing debate on the cancer-preventive properties of nat-
ural compounds is that dietary consumption is insufficient to achieve
cancer inhibitory concentrations at target tissues [17–21]. However,
resveratrol, quercetin, and catechins are all considered viable chemo-
preventives because they are absorbed and metabolized rapidly in vivo
and can be detected in plasma and urine samples in the intact form in
humans and rodent models [5,17–21]. Data on bioavailability of grape
polyphenols following consumption in animal models vary depending
Figure 6. (continued).
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on the route of administration, animal models, and method of detec-
tion. For example, administration of as little as 50 μg/kg body weight
of resveratrol per day for 3 months to rats achieved serum levels as
high as 8.0 μM [39]. However, others have shown that administra-
tion of 20 mg/kg resveratrol to rats, mice, or rabbits demonstrated a
very short half-life (10 minutes) and reached circulating levels of less
than 1 μM very rapidly [20]. Similarly, following 20 mg/kg body
weight administration of quercetin to mice, at concentrations that
inhibited metastatic melanoma growth, the quercetin levels in the
plasma decreased to ∼ 1 μM after 120 minutes [21]. Therefore,
the combined polyphenols that demonstrated reduced mammary
tumor growth in this study at 5 mg/kg body weight must be effec-
tive at the cellular level at very low concentrations.
As has been reported previously for this cell line [32,51], MDA-
MB-231 cells did not form significant metastases during the 4-month
study period. Isolated lungs from mice that received only vehicle con-
trol demonstrated more micrometastases (2–10 cells) compared to
mice treated with polyphenols. However, these differences were not
statistically significant due to the small sample size of the mice that
developedmetastases. Therefore, we were unable to perform a compre-
hensive analysis of the effect of resveratrol, quercetin, and catechin on
breast cancer metastasis. Resveratrol at similar concentrations has been
shown to reduce lung metastasis in other systems [52,53]. A recent
study demonstrated that grape polyphenols, including resveratrol, epi-
catechin, and epigallocatechin, can inhibit cancer cell invasion [54].
The contribution of combined grape polyphenols on prevention of
metastasis or progression of established breast cancers will be a focus
of future investigations using more efficient metastatic breast cancer
cell lines. Overall, the data presented indicate a preventive/therapeutic
role for dietary grape polyphenols in primary breast cancer. However,
more animal and clinical studies are needed before dietary recommen-
dations of grape products for breast cancer patients, for those at risk, or
for survivors of breast cancer can be made.
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